{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T23:40:12Z","timestamp":1736466012892,"version":"3.32.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000},"content-version":"vor","delay-in-days":1735,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["intpsychogeriatrics.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Psychogeriatrics"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1017\/s1041610219000760","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T08:37:41Z","timestamp":1587026261000},"page":"419-422","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plus \u00e7a change? Benzodiazepine prescription in older patients with schizophrenia is common but best avoided"],"prefix":"10.1016","volume":"32","author":[{"given":"Simon J.C.","family":"Davies","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benoit H.","family":"Mulsant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1017\/S1041610219000760_bb0010","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1177\/0269881113503509","article-title":"Benzodiazepines: risks and benefits. A reconsideration","volume":"27","author":"Baldwin","year":"2013","journal-title":"Journal of Psychopharmacology"},{"key":"10.1017\/S1041610219000760_bb0015","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/0269881114525674","article-title":"Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology","volume":"28","author":"Baldwin","year":"2014","journal-title":"Journal of Psychopharmacology"},{"key":"10.1017\/S1041610219000760_bb0020","article-title":"Benzodiazepines for antipsychotic-induced tardive dyskinesia","volume":"1","author":"Bergman","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1017\/S1041610219000760_bb0025","first-page":"1317","article-title":"Alprazolam in young and elderly men: sensitivity and tolerance to psychomotor, sedative and memory effects","volume":"281","author":"Bertz","year":"1997","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1017\/S1041610219000760_bb0030","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1017\/S1041610217002587","article-title":"Prevalence and risk factors for delirium diagnosis in patients followed in general practices in Germany","volume":"30","author":"Bohlken","year":"2018","journal-title":"International Psychogeriatrics"},{"key":"10.1017\/S1041610219000760_bb0035","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1017\/S1041610218001229","article-title":"Prescribing of psychotropic drugs and indicators for use in residential aged care and residents with dementia","volume":"31","author":"Brimelow","year":"2018","journal-title":"International Psychogeriatrics"},{"key":"10.1017\/S1041610219000760_bb0040","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.jagp.2016.04.013","article-title":"Benzodiazepine use attenuates cortical \u03b2-amyloid and is not associated with progressive cognitive decline in nondemented elderly adults: a Pilot Study using F18-Florbetapir positron emission tomography","volume":"24","author":"Chung","year":"2016","journal-title":"The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry"},{"key":"10.1017\/S1041610219000760_bb0045","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/arclin\/acx120","article-title":"The residual medium and long-term cognitive effects of benzodiazepine use: an updated meta-analysis","volume":"33","author":"Crowe","year":"2018","journal-title":"Archives of Clinical Neuropsychology"},{"key":"10.1017\/S1041610219000760_bb0050","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2165\/00023210-200317110-00004","article-title":"Benzodiazepines and risk of hip fractures in older people: a review of the evidence","volume":"17","author":"Cumming","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1017\/S1041610219000760_bb0055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/2045125317743651","article-title":"Benzodiazepine prescription in Ontario residents aged 65 and over: a population-based study from 1998 to 2013","volume":"8","author":"Davies","year":"2018","journal-title":"Therapeutic Advances in Psychopharmacology"},{"key":"10.1017\/S1041610219000760_bb0060","article-title":"Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study","volume":"352","author":"Gray","year":"2016","journal-title":"BMJ"},{"key":"10.1017\/S1041610219000760_bb0065","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1600-0447.1989.tb01308.x","article-title":"Successful treatment with clonazepam for neuroleptic-induced akathisia","volume":"80","author":"Horiguchi","year":"1989","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1017\/S1041610219000760_bb0070","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4088\/JCP.v60n0109","article-title":"The efficacy and safety of clozapine versus chlorpromazine in geriatric schizophrenia","volume":"60","author":"Howanitz","year":"1999","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1017\/S1041610219000760_bb0075","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/00019442-200311000-00008","article-title":"International multisite double-blind trial of the atypical antipsychotics risperidone and olanzapine in 175 elderly patients with chronic schizophrenia","volume":"11","author":"Jeste","year":"2003","journal-title":"The American Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610219000760_bb0080","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1176\/ajp.145.6.742","article-title":"Adjunctive alprazolam for schizophrenia with panic anxiety: clinical observation and pathogenetic implications","volume":"145","author":"Kahn","year":"1988","journal-title":"The American Journal of Psychiatry"},{"key":"10.1017\/S1041610219000760_bb0085","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/1471-244X-14-S1-S1","article-title":"Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders","volume":"14","author":"Katzman","year":"2014","journal-title":"BMC Psychiatry"},{"key":"10.1017\/S1041610219000760_bb0090","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nrn1648","article-title":"Cortical inhibitory neurons and schizophrenia","volume":"6","author":"Lewis","year":"2005","journal-title":"Nature Reviews Neuroscience"},{"key":"10.1017\/S1041610219000760_bb0095","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1017\/S1041610217002745","article-title":"Association between the use of benzodiazepines and opioids with the risk of falls and hip fractures in older adults","volume":"30","author":"Machado-Duque","year":"2018","journal-title":"International Psychogeriatrics"},{"key":"10.1017\/S1041610219000760_bb0100","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00441-006-0284-3","article-title":"GABAA receptor diversity and pharmacology","volume":"326","author":"M\u00f6hler","year":"2006","journal-title":"Cell and Tissue Research"},{"author":"Sampson","key":"10.1017\/S1041610219000760_bb0105"},{"key":"10.1017\/S1041610219000760_bb0110","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1017\/S1041610219000358","article-title":"Benzodiazepine use among older adults with schizophrenia spectrum disorder","volume":"32","author":"Schuster","year":"2019","journal-title":"International Psychogeriatrics"},{"key":"10.1017\/S1041610219000760_bb0115","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/0269881114541013","article-title":"Re-examining the role of benzodiazepines in the treatment of schizophrenia: a systematic review","volume":"29","author":"Sim","year":"2015","journal-title":"Journal of Psychopharmacology"},{"key":"10.1017\/S1041610219000760_bb0120","first-page":"799","article-title":"Benzodiazepine use and motor vehicle accidents. Systematic review of reported association","volume":"44","author":"Thomas","year":"1998","journal-title":"Canadian Family Physician"},{"key":"10.1017\/S1041610219000760_bb0125","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/JGP.0b013e31815a3e7a","article-title":"Safety and tolerability of oral paliperidone extended-release tablets in elderly patients with schizophrenia: a double-blind, placebo-controlled study with six-month open-label extension","volume":"16","author":"Tzimos","year":"2008","journal-title":"The American Journal of Geriatric Psychiatry"}],"container-title":["International Psychogeriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224024967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224024967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1041610219000760","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T23:08:21Z","timestamp":1736464101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1041610224024967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S1041610224024967"],"URL":"https:\/\/doi.org\/10.1017\/s1041610219000760","relation":{},"ISSN":["1041-6102"],"issn-type":[{"type":"print","value":"1041-6102"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plus \u00e7a change? Benzodiazepine prescription in older patients with schizophrenia is common but best avoided","name":"articletitle","label":"Article Title"},{"value":"International Psychogeriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1017\/S1041610219000760","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 International Psychogeriatric Association. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}